Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Novel Na+/H+ exchange inhibitor effective against reperfusion injury in rat MI model

May 6, 1999

FR-172516: pharmacological characterization of dual Ca2+ channel and beta-adrenoceptor blocker

May 6, 1999

AH-1058: new antiarrhythmic agent with unique profile of activity

May 5, 1999

U.S. patent issued last month covers Warner-Lambert's new ECE inhibitors

May 5, 1999

FDA panel votes to recommend approval for Betapace

May 5, 1999

Adenosine reduces complications in CABG

May 4, 1999

Intracoronary pyruvate has inotropic activity in patients with CHF

May 3, 1999

Urea-based compounds from AHP increase HDL cholesterol levels

April 30, 1999

HMR describes new NCBE inhibitor series for cardiovascular disorders

April 29, 1999

Pyrazoles acting as modulators of cGMP production disclosed by Hoechst Marion Roussel

April 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...